V7A0 Stock Overview Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteThe Beauty Health Company Competitors Price History & Performance
Summary of share price highs, lows and changes for Beauty Health Historical stock prices Current Share Price US$1.53 52 Week High US$4.40 52 Week Low US$0.81 Beta 0.82 1 Month Change -4.38% 3 Month Change 17.69% 1 Year Change -42.91% 3 Year Change -90.95% 5 Year Change n/a Change since IPO -84.77%
Recent News & Updates
The Beauty Health Company Appoints Stephen J. Fanning as Board of Directors Dec 18
The Beauty Health Company Revises Earnings Guidance for Fiscal Year 2024 Nov 14
Third quarter 2024 earnings released: US$0.15 loss per share (vs US$0.56 loss in 3Q 2023) Nov 13
The Beauty Health Company to Report Q3, 2024 Results on Nov 12, 2024 Nov 08
The Beauty Health Company Announces Termination of Daniel Watson as Chief Revenue Officer Oct 18
The Beauty Health Company Announces Management Changes Oct 16 See more updates
The Beauty Health Company Appoints Stephen J. Fanning as Board of Directors Dec 18
The Beauty Health Company Revises Earnings Guidance for Fiscal Year 2024 Nov 14
Third quarter 2024 earnings released: US$0.15 loss per share (vs US$0.56 loss in 3Q 2023) Nov 13
The Beauty Health Company to Report Q3, 2024 Results on Nov 12, 2024 Nov 08
The Beauty Health Company Announces Termination of Daniel Watson as Chief Revenue Officer Oct 18
The Beauty Health Company Announces Management Changes Oct 16
The Beauty Health Company Introduces New Clinically Proven Hydralock HA Booster Oct 15
New minor risk - Profitability Sep 18
Second quarter 2024 earnings released: EPS: US$0.002 (vs US$0.025 in 2Q 2023) Aug 09
the Beauty Health Company Revises Earnings Guidance for the Third Quarter and Fiscal Year 2024 Aug 09
Now 21% undervalued after recent price drop Aug 01
The Beauty Health Company to Report Q2, 2024 Results on Aug 06, 2024 Jul 30
Insufficient new directors Jul 01
High number of new directors May 29
The Beauty Health Company Provides Net Sales Guidance for the Second Quarter of 2024 May 11 The Beauty Health Company to Report Q1, 2024 Results on May 09, 2024
Beauty Health Company Appoints Sheri Lewis as Chief Supply Chain and Operations Officer Apr 10
the Beauty Health Company Provides Earnings Guidance for First Quarter and Full Year 2024 Mar 13 The Beauty Health Company announced delayed annual 10-K filing
The Beauty Health Company to Report Q4, 2023 Results on Feb 29, 2024 Feb 28
High number of new and inexperienced directors Feb 13 Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against the Beauty Health Company Nov 17
The Beauty Health Company Announces CEO Changes
The Beauty Health Company to Report Q3, 2023 Results on Nov 13, 2023 Nov 08
The Beauty Health Company (NasdaqCM:SKIN) announces an Equity Buyback for $100 million worth of its shares. Sep 14 The Beauty Health Company (NasdaqCM:SKIN) announces an Equity Buyback for $100 million worth of its shares. Sep 13
Chairman recently bought €332k worth of stock Aug 20 The Beauty Health Company Provides Revenue Guidance for Fiscal Year 2023 and Fiscal Year 2025
Second quarter 2023 earnings released: EPS: US$0.026 (vs US$0.053 in 2Q 2022) Aug 10
The Beauty Health Company's SkinStylus™ Receives New FDA Clearance for Facial Acne Scarring Aug 03
The Beauty Health Company to Report Q2, 2023 Results on Aug 09, 2023 Jul 28
The Beauty Health Company Debuts Custom Syndeo Device on Dior Spa Cruise 2023 Jul 18
The Beauty Health Company Provides Earnings Guidance for the Year 2023 May 11
First quarter 2023 earnings released: US$0.17 loss per share (vs US$0.22 profit in 1Q 2022) May 10
Investor sentiment deteriorates as stock falls 15% Apr 26
Now 21% undervalued Apr 25
Now 20% undervalued Mar 23
Full year 2022 earnings released: EPS: US$0.30 (vs US$3.67 loss in FY 2021) Mar 01
Investor sentiment deteriorates as stock falls 17% Feb 22
The Beauty Health Company to Report Q4, 2022 Results on Feb 28, 2023 Feb 15
Investor sentiment improves as stock rises 16% Feb 03
The Beauty Health Company Promotes Daniel Watson to the Position of Chief Revenue Officer Jan 07
The Beauty Health Company’s Hydrafacial Launches New Booster Developed with BABOR Laboratories in Germany Dec 08
High number of new and inexperienced directors Nov 16
Third quarter 2022 earnings released: EPS: US$0.001 (vs US$1.63 loss in 3Q 2021) Nov 09
The Beauty Health Company Revises Earnings Guidance for the Fiscal Year 2022 Nov 09 The Beauty Health Company Unveils A New Exfoliating Booster Co-Created with Dermatological Skincare Brand, Glytone
The Beauty Health Company Appoints David Aquino as Executive Vice President Global Operations Nov 03
The Beauty Health Company to Report Q3, 2022 Results on Nov 08, 2022 Oct 26
the Beauty Health Company Announces Highly Anticipated Hydrafacial x JLo Beauty Booster Now Available in the U.S Oct 06
The Beauty Health Company (NasdaqCM:SKIN) announces an Equity Buyback for $200 million worth of its shares. Sep 28
Forecast breakeven date pushed back to 2024 Sep 13
The Beauty Health Company Announces Executive Appointments Aug 30
Stephan Becker, President of EMEA of the Beauty Health Company Transitions Out of the Company Aug 27
Second quarter 2022 earnings released: EPS: US$0.053 (vs US$1.52 loss in 2Q 2021) Aug 10
The Beauty Health Company Provides Sales Guidance for the Fiscal Year 2022 Aug 10
The Beauty Health Company to Report Q2, 2022 Results on Aug 09, 2022 Jul 28
The Beauty Health Company Appoints Ms. Beck to Serve as A Member of the Audit Committee Jun 30 The Beauty Health Company(NasdaqCM:SKIN) dropped from Russell Microcap Value Index
The Beauty Health Company Announces Indra Pamamull Has Transitioned Out as President of Apac Jun 11
The Beauty Health Company Appoints Marla Beck to its Board of Directors Jun 07
The Beauty Health Company Revises Earnings Guidance for the Year 2022 May 12
First quarter 2022 earnings released: EPS: US$0.22 (vs US$0.092 loss in 1Q 2021) May 11 The Beauty Health Company Appoints Amy Juaristi as Head of Corporate Affairs May 10
High number of new and inexperienced directors Apr 27
The Beauty Health Company, Annual General Meeting, Jun 28, 2022 Apr 26
The Beauty Health Company Introduces New Digitally Connected HydraFacial Syndeo™ Delivery System Mar 10
Forecast breakeven date pushed back to 2024 Mar 09
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Feb 24
The Beauty Health Company Provides Revenue Guidance for the Fiscal Year 2022 Feb 24
The Beauty Health Company to Report Q4, 2021 Results on Feb 22, 2022 Feb 08
Forecast breakeven date pushed back to 2023 Jan 29
The Beauty Health Company Revises Earnings Guidance for the Fiscal Year 2021 Jan 12
No longer forecast to breakeven Dec 24
Third quarter 2021 earnings released: US$1.63 loss per share (vs US$0.063 loss in 3Q 2020) Nov 11
Forecast to breakeven in 2022 Sep 23
HydraFacial Launches GLOWvolution Jun 08
The Beauty Health Company Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report May 21
The Beauty Health Company announced delayed 10-Q filing May 19
The Beauty Health Company Provides Earnings Guidance for the Fiscal Year 2021 May 15 Shareholder Returns V7A0 DE Personal Products DE Market 7D -2.5% 0.6% -0.6% 1Y -42.9% -11.6% 14.8%
See full shareholder returns
Return vs Market: V7A0 underperformed the German Market which returned 14.9% over the past year.
Price Volatility Is V7A0's price volatile compared to industry and market? V7A0 volatility V7A0 Average Weekly Movement 8.9% Personal Products Industry Average Movement 3.6% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.5% 10% least volatile stocks in DE Market 2.6%
Stable Share Price: V7A0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: V7A0's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
Show more The Beauty Health Company Fundamentals Summary How do Beauty Health's earnings and revenue compare to its market cap? V7A0 fundamental statistics Market cap €191.02m Earnings (TTM ) -€26.93m Revenue (TTM ) €332.29m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) V7A0 income statement (TTM ) Revenue US$347.62m Cost of Revenue US$171.98m Gross Profit US$175.64m Other Expenses US$203.81m Earnings -US$28.17m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.23 Gross Margin 50.53% Net Profit Margin -8.10% Debt/Equity Ratio 923.3%
How did V7A0 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/22 14:20 End of Day Share Price 2025/02/21 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources The Beauty Health Company is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Bruce Jackson Benchmark Company Navann Ty Dietschi BNP Paribas Exane Kyle Rose Canaccord Genuity
Show 11 more analysts